Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 12 studies | 31% ± 6% | |
| type II pneumocyte | 7 studies | 27% ± 11% | |
| endothelial cell | 5 studies | 26% ± 10% | |
| glutamatergic neuron | 5 studies | 40% ± 16% | |
| epithelial cell | 5 studies | 26% ± 6% | |
| GABAergic neuron | 5 studies | 32% ± 16% | |
| neuron | 4 studies | 22% ± 5% | |
| interneuron | 4 studies | 26% ± 15% | |
| oligodendrocyte precursor cell | 3 studies | 20% ± 4% | |
| basal cell | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3133.54 | 1445 / 1445 | 100% | 93.26 | 183 / 183 |
| liver | 100% | 3208.98 | 226 / 226 | 100% | 52.78 | 406 / 406 |
| lung | 100% | 6165.70 | 578 / 578 | 100% | 74.70 | 1154 / 1155 |
| skin | 100% | 5052.51 | 1809 / 1809 | 100% | 65.17 | 471 / 472 |
| intestine | 100% | 3115.27 | 966 / 966 | 100% | 51.63 | 525 / 527 |
| prostate | 100% | 3034.91 | 245 / 245 | 100% | 50.13 | 500 / 502 |
| uterus | 100% | 2238.75 | 170 / 170 | 100% | 59.21 | 457 / 459 |
| breast | 100% | 2164.32 | 459 / 459 | 100% | 68.76 | 1113 / 1118 |
| brain | 99% | 3338.59 | 2625 / 2642 | 100% | 50.19 | 704 / 705 |
| stomach | 100% | 2895.38 | 359 / 359 | 99% | 55.01 | 283 / 286 |
| thymus | 100% | 2900.21 | 653 / 653 | 99% | 43.43 | 598 / 605 |
| bladder | 100% | 2914.67 | 21 / 21 | 98% | 57.27 | 496 / 504 |
| ovary | 100% | 1949.03 | 180 / 180 | 98% | 43.83 | 423 / 430 |
| kidney | 100% | 2386.10 | 89 / 89 | 98% | 38.35 | 881 / 901 |
| adrenal gland | 100% | 2918.28 | 258 / 258 | 96% | 46.44 | 221 / 230 |
| pancreas | 95% | 1096.71 | 310 / 328 | 99% | 43.75 | 176 / 178 |
| muscle | 100% | 4568.67 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1604.95 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 62.41 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 45.57 | 1 / 1 |
| adipose | 100% | 2033.97 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1759.02 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 1812.61 | 921 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 53.64 | 79 / 80 |
| heart | 97% | 2380.80 | 837 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 15.30 | 26 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007605 | Biological process | sensory perception of sound |
| GO_0098655 | Biological process | monoatomic cation transmembrane transport |
| GO_0160069 | Biological process | surfactant secretion |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0097233 | Cellular component | alveolar lamellar body membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0140135 | Molecular function | mechanosensitive monoatomic cation channel activity |
| GO_1990760 | Molecular function | osmolarity-sensing monoatomic cation channel activity |
| GO_0008381 | Molecular function | mechanosensitive monoatomic ion channel activity |
| GO_0005227 | Molecular function | calcium-activated cation channel activity |
| Gene name | TMEM63B |
| Protein name | Transmembrane protein 63B CSC1-like protein 2 (Transmembrane protein 63B) |
| Synonyms | C6orf110 |
| Description | FUNCTION: Acts as an osmosensitive calcium-permeable cation channel (By similarity). Mechanosensitive ion channel that converts mechanical stimuli into a flow of ion . Acts as an inner ear osmosensor, essential for normal hearing and survival of inner ear outer hair cells (OHCs). Mediates calcium-dependent regulatory volume decrease in OHCs which is necessary for their survival. Required for the maintenance of the morphological integrity of OHCs under hypotonic conditions. Mediates hypo-osmolarity-induced calcium influx, leading to activation of calcium-dependent potassium channels required for the maintenance of OHC morphology (By similarity). . |
| Accessions | ENST00000533121.1 ENST00000371893.6 Q5T3F8 H0YCP6 H3BLW6 ENST00000259746.13 [Q5T3F8-1] ENST00000323267.11 [Q5T3F8-1] E9PNG1 ENST00000532634.5 H0YDJ6 ENST00000497371.6 |